Marsha Fanucci
Chief Financial Officer, MILLENNIUM PHARMACEUTICALS INC.
Companies
- Generate Biomedicines, Inc.Board member Feb 26, 2026 to now1
- Syros Pharmaceuticals, Inc.Board member Jun 29, 2016 to Jun 7, 20242
- Alnylam PharmaceuticalsBoard member Dec 10, 2010 to May 19, 20233
- Forma Therapeutics Holdings, Inc.Board member Jun 18, 2020 to Oct 14, 20224
- Korsana Biosciences, Inc.Board member Mar 15, 2019 to Jun 16, 20225
- Ironwood PharmaceuticalsBoard member Feb 2, 2010 to Apr 3, 20196
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Alnylam Pharmaceuticals ALNY136 shares7$32.0K at $235.58Feb 23, 2023- Forma Therapeutics Holdings, Inc.0 shares8Oct 14, 2022
- Syros Pharmaceuticals, Inc.16,000 shares9Jun 5, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 5, 2024Granted 4,000 shares of Syros Pharmaceuticals, Inc.9
- Jun 1, 2023Granted 4,000 shares of Syros Pharmaceuticals, Inc.10
- Feb 23, 2023Exercised options 136 shares of Alnylam Pharmaceuticals7
- Oct 14, 2022U 7,250 shares of Forma Therapeutics Holdings, Inc.8
- Oct 14, 2022U 52,532 shares of Forma Therapeutics Holdings, Inc.8
- Sep 16, 2022Granted 8,000 shares of Syros Pharmaceuticals, Inc.11
- Jun 8, 2022Granted 4,500 shares of Forma Therapeutics Holdings, Inc.12
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10SEC EDGARForm 4 filed Jun 2, 2023
- 11SEC EDGARForm 4 filed Sep 19, 2022
- 12SEC EDGARForm 4 filed Jun 9, 2022